Average Co-Inventor Count = 3.78
ph-index = 16
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Vertex Pharmaceuticals, Inc. (20 from 1,151 patents)
2. Other (6 from 832,843 patents)
3. Neurocrine Biosciences, Inc. (5 from 120 patents)
4. Napp Pharmaceutical Group Limited (2 from 3 patents)
5. Cidara Therapeutics, Inc. (1 from 15 patents)
34 patents:
1. 12415798 - Processes for making modulators of cystic fibrosis transmembrane conductance regulator
2. 12384762 - Modulator of the Cystic Fibrosis Transmembrane Conductance Regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
3. 12146006 - Synthesis of echinocandin antifungal agent
4. 12060439 - Polymorph of echinocandin antifungal agent
5. 11524980 - Synthesis of echinocandin antifungal agent
6. 11465985 - Processes for making modulators of cystic fibrosis transmembrane conductance regulator
7. 11459305 - Processes for the preparation of uracil derivatives
8. 11453655 - Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
9. 11434201 - Processes for preparing pyrrolidine compounds
10. 11186566 - Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
11. 10822331 - Processes for preparing ATR inhibitors
12. 10793547 - Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
13. 10570115 - Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
14. 10494347 - Processes for the preparation of uracil derivatives
15. 10208027 - Processes for preparing ATR inhibitors